US Stock MarketDetailed Quotes

Aligos Therapeutics (ALGS)

Watchlist
  • 6.680
  • -0.980-12.79%
Close Apr 17 16:00 ET
  • 6.700
  • +0.020+0.30%
Post 20:01 ET
41.33MMarket Cap-2.73P/E (TTM)

Aligos Therapeutics (ALGS) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
-44.59%2.19M
-73.13%169K
-41.61%741K
-9.05%965K
-68.46%311K
-74.60%3.95M
-76.54%629K
-60.82%1.27M
-84.59%1.06M
-63.79%986K
Operating revenue
-44.59%2.19M
-73.13%169K
-41.61%741K
-9.05%965K
-68.46%311K
-74.60%3.95M
-76.54%629K
-60.82%1.27M
-84.59%1.06M
-63.79%986K
Cost of revenue
Gross profit
Operating expense
-3.15%90.17M
3.73%21.98M
35.99%29.1M
-28.91%19.53M
-15.10%19.55M
-10.18%93.1M
-26.10%21.19M
-4.08%21.4M
5.56%27.48M
-13.55%23.03M
Selling and administrative expenses
-9.25%20.72M
-4.19%4.95M
11.65%5.17M
-12.86%5.56M
-24.21%5.05M
-25.43%22.83M
-19.62%5.16M
-28.20%4.63M
-31.04%6.38M
-21.63%6.67M
-General and administrative expense
-9.25%20.72M
-4.19%4.95M
11.65%5.17M
-12.86%5.56M
-24.21%5.05M
-25.43%22.83M
-19.62%5.16M
-28.20%4.63M
-31.04%6.38M
-21.63%6.67M
Research and development costs
-1.16%69.45M
6.28%17.04M
42.70%23.94M
-33.76%13.98M
-11.39%14.5M
-3.79%70.27M
-27.97%16.03M
5.72%16.77M
25.73%21.1M
-9.75%16.37M
Operating profit
1.31%-87.99M
-6.08%-21.81M
-40.88%-28.36M
29.71%-18.57M
12.71%-19.24M
-1.17%-89.15M
20.90%-20.56M
-5.56%-20.13M
-38.00%-26.41M
7.83%-22.05M
Net non-operating interest income expense
-10.99%3.92M
-24.39%2.31M
-17.29%378K
24.14%396K
45.17%842K
29.13%4.41M
333.24%3.05M
-54.53%457K
-66.60%319K
-22.46%580K
Non-operating interest income
----
----
-17.29%378K
24.14%396K
45.17%842K
----
----
-54.53%457K
-66.60%319K
-22.46%580K
Total other finance cost
10.99%-3.92M
----
----
----
----
-29.13%-4.41M
----
----
----
----
Other net income (expense)
230.46%60.18M
99.47%-343K
-791.30%-3.5M
-92.05%2.49M
560.12%61.53M
-2,026.88%-46.13M
-2,357.59%-64.61M
837.04%506K
20,521.71%31.35M
-5,364.96%-13.37M
Gain on sale of security
230.46%60.18M
101.95%1.21M
-3,904.76%-4.21M
-94.47%1.68M
527.87%61.49M
-2,026.88%-46.13M
---62.13M
---105K
--30.44M
---14.37M
Other non- operating income (expenses)
----
----
15.71%707K
-10.68%811K
-96.20%38K
----
----
1,031.48%611K
497.37%908K
293.31%999K
Income before tax
81.76%-23.88M
75.83%-19.85M
-64.24%-31.48M
-398.63%-15.68M
223.80%43.13M
-50.64%-130.88M
-194.12%-82.12M
-6.42%-19.17M
129.11%5.25M
-52.03%-34.84M
Income tax
-5.14%314K
11.11%30K
-38.46%56K
-2.12%185K
79.17%43K
-58.36%331K
190.00%27K
213.79%91K
-75.03%189K
-38.46%24K
Net income
81.56%-24.19M
75.80%-19.88M
-63.75%-31.54M
-413.44%-15.86M
223.59%43.09M
-49.65%-131.21M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
Net income continuous Operations
81.56%-24.19M
75.80%-19.88M
-63.75%-31.54M
-413.44%-15.86M
223.59%43.09M
-49.65%-131.21M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
Minority interest income
Net income attributable to the parent company
81.56%-24.19M
75.80%-19.88M
-63.75%-31.54M
-413.44%-15.86M
223.59%43.09M
-49.65%-131.21M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
81.56%-24.19M
75.80%-19.88M
-63.75%-31.54M
-413.44%-15.86M
223.59%43.09M
-49.65%-131.21M
-194.53%-82.15M
-6.75%-19.26M
126.93%5.06M
-51.88%-34.86M
Basic earnings per share
88.30%-2.45
85.40%-1.91
0.98%-3.04
-288.89%-1.53
191.76%5.12
38.77%-20.94
-40.87%-13.08
70.40%-3.07
107.53%0.81
57.89%-5.58
Diluted earnings per share
88.30%-2.45
85.40%-1.91
0.98%-3.04
-288.89%-1.53
62.19%-2.11
38.77%-20.94
-40.87%-13.08
70.40%-3.07
107.53%0.81
57.89%-5.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue -44.59%2.19M-73.13%169K-41.61%741K-9.05%965K-68.46%311K-74.60%3.95M-76.54%629K-60.82%1.27M-84.59%1.06M-63.79%986K
Operating revenue -44.59%2.19M-73.13%169K-41.61%741K-9.05%965K-68.46%311K-74.60%3.95M-76.54%629K-60.82%1.27M-84.59%1.06M-63.79%986K
Cost of revenue
Gross profit
Operating expense -3.15%90.17M3.73%21.98M35.99%29.1M-28.91%19.53M-15.10%19.55M-10.18%93.1M-26.10%21.19M-4.08%21.4M5.56%27.48M-13.55%23.03M
Selling and administrative expenses -9.25%20.72M-4.19%4.95M11.65%5.17M-12.86%5.56M-24.21%5.05M-25.43%22.83M-19.62%5.16M-28.20%4.63M-31.04%6.38M-21.63%6.67M
-General and administrative expense -9.25%20.72M-4.19%4.95M11.65%5.17M-12.86%5.56M-24.21%5.05M-25.43%22.83M-19.62%5.16M-28.20%4.63M-31.04%6.38M-21.63%6.67M
Research and development costs -1.16%69.45M6.28%17.04M42.70%23.94M-33.76%13.98M-11.39%14.5M-3.79%70.27M-27.97%16.03M5.72%16.77M25.73%21.1M-9.75%16.37M
Operating profit 1.31%-87.99M-6.08%-21.81M-40.88%-28.36M29.71%-18.57M12.71%-19.24M-1.17%-89.15M20.90%-20.56M-5.56%-20.13M-38.00%-26.41M7.83%-22.05M
Net non-operating interest income expense -10.99%3.92M-24.39%2.31M-17.29%378K24.14%396K45.17%842K29.13%4.41M333.24%3.05M-54.53%457K-66.60%319K-22.46%580K
Non-operating interest income ---------17.29%378K24.14%396K45.17%842K---------54.53%457K-66.60%319K-22.46%580K
Total other finance cost 10.99%-3.92M-----------------29.13%-4.41M----------------
Other net income (expense) 230.46%60.18M99.47%-343K-791.30%-3.5M-92.05%2.49M560.12%61.53M-2,026.88%-46.13M-2,357.59%-64.61M837.04%506K20,521.71%31.35M-5,364.96%-13.37M
Gain on sale of security 230.46%60.18M101.95%1.21M-3,904.76%-4.21M-94.47%1.68M527.87%61.49M-2,026.88%-46.13M---62.13M---105K--30.44M---14.37M
Other non- operating income (expenses) --------15.71%707K-10.68%811K-96.20%38K--------1,031.48%611K497.37%908K293.31%999K
Income before tax 81.76%-23.88M75.83%-19.85M-64.24%-31.48M-398.63%-15.68M223.80%43.13M-50.64%-130.88M-194.12%-82.12M-6.42%-19.17M129.11%5.25M-52.03%-34.84M
Income tax -5.14%314K11.11%30K-38.46%56K-2.12%185K79.17%43K-58.36%331K190.00%27K213.79%91K-75.03%189K-38.46%24K
Net income 81.56%-24.19M75.80%-19.88M-63.75%-31.54M-413.44%-15.86M223.59%43.09M-49.65%-131.21M-194.53%-82.15M-6.75%-19.26M126.93%5.06M-51.88%-34.86M
Net income continuous Operations 81.56%-24.19M75.80%-19.88M-63.75%-31.54M-413.44%-15.86M223.59%43.09M-49.65%-131.21M-194.53%-82.15M-6.75%-19.26M126.93%5.06M-51.88%-34.86M
Minority interest income
Net income attributable to the parent company 81.56%-24.19M75.80%-19.88M-63.75%-31.54M-413.44%-15.86M223.59%43.09M-49.65%-131.21M-194.53%-82.15M-6.75%-19.26M126.93%5.06M-51.88%-34.86M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 81.56%-24.19M75.80%-19.88M-63.75%-31.54M-413.44%-15.86M223.59%43.09M-49.65%-131.21M-194.53%-82.15M-6.75%-19.26M126.93%5.06M-51.88%-34.86M
Basic earnings per share 88.30%-2.4585.40%-1.910.98%-3.04-288.89%-1.53191.76%5.1238.77%-20.94-40.87%-13.0870.40%-3.07107.53%0.8157.89%-5.58
Diluted earnings per share 88.30%-2.4585.40%-1.910.98%-3.04-288.89%-1.5362.19%-2.1138.77%-20.94-40.87%-13.0870.40%-3.07107.53%0.8157.89%-5.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More